Australia on Friday blocked ​a A$672 million ($433 ‌million) buyout offer for Mayne Pharma ‌from U. drugmaker Cosette Pharmaceuticals, citing national interest.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback